Literature DB >> 9669343

Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma: a clinicopathologic and immunohistochemical study of five cases.

R H Young1, W R Hart.   

Abstract

Five cases of ovarian metastases of intestinal adenocarcinomas that suggested the diagnosis of clear cell adenocarcinoma or the secretory variant of endometrioid carcinoma of the ovary are reported. Patient age ranged from 27 to 71 years at the time of diagnosis of the ovarian neoplasms. In four, the ovarian and intestinal tumors were discovered synchronously, and, in the fifth, the ovarian metastasis occurred 1 year after the intestinal primary was diagnosed. The ovarian tumors were unilateral in three patients and bilateral in two. They were up to 18 cm (mean, 12 cm) in maximum dimension and were characterized on microscopic evaluation by glands and cysts lined by cells whose most striking feature was abundant clear cytoplasm. In two cases, striking subnuclear or supranuclear vacuoles were present. An important clue to the diagnosis of metastatic intestinal adenocarcinoma was the presence in all cases of "dirty necrosis." The metastatic nature of the ovarian tumors was supported by the immunohistochemical findings. All tumors stained were strongly positive for carcinoembryonic antigen and cytokeratin 20 and failed to stain for CA125, whereas staining for HAM56 and cytokeratin 7 was absent or only focally positive in one case each. Three intestinal primary tumors involved the small bowel. Microscopic evaluation of the intestinal tumors in three cases and metastases in a fourth, in which the intestinal primary was not resected, showed the features of the uncommon clear cell variant of intestinal adenocarcinoma; the fifth was predominantly a conventional intestinal adenocarcinoma with only a focal clear cell component. Although intestinal adenocarcinomas metastatic in the ovary typically simulate endometrioid adenocarcinoma of the usual type or mucinous adenocarcinoma, they may mimic either primary clear cell adenocarcinoma or the secretory variant of endometrioid adenocarcinoma, particularly when the primary tumor is, even focally, the clear cell variant of intestinal adenocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9669343     DOI: 10.1097/00000478-199807000-00003

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

Review 1.  [Intraoperative frozen sections in diseases of the female genital tract].

Authors:  S Lax; K Tamussino; K Prein; P Lang
Journal:  Pathologe       Date:  2012-09       Impact factor: 1.011

2.  Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma.

Authors:  Gozde Kir; Ayse Gurbuz; Ates Karateke; Mustafa Kir
Journal:  World J Gastrointest Surg       Date:  2010-04-27

Review 3.  Rectal mucosal endometriosis primarily misinterpreted as adenocarcinoma: a case report and review of literature.

Authors:  Hui Chen; Qiuping Luo; Shaoyan Liu; Hanzhen Xiong; Qingping Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  [Differential diagnosis of ovarian metastases].

Authors:  S Hauptmann
Journal:  Pathologe       Date:  2007-05       Impact factor: 1.011

5.  Colon metastasis 20 years after the removal of ovarian cancer: Report of a case.

Authors:  Kotaro Shibahara; Kazuya Endo; Tetuo Ikeda; Hisanobu Sakata; Noriaki Sadanaga; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Surg Today       Date:  2009-02-07       Impact factor: 2.549

6.  Right Colon Clear Cell Carcinoma of Müllerian Type.

Authors:  Fahd Khefacha; Wissem Triki; Karim Ayed; Imed Abbassi; Abdelmajid Baccar; Oussema Baraket; Sami Bouchoucha
Journal:  Case Rep Gastroenterol       Date:  2022-08-19

7.  Is Routine Gastroscopy/Colonoscopy Reasonable in Patients With Suspected Ovarian Cancer: A Retrospective Study.

Authors:  Guochen Liu; Junping Yan; Shanshan Long; Zhimin Liu; Haifeng Gu; Hua Tu; Jundong Li
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.